Post by
SteveMcM on Nov 19, 2015 10:33pm
Valstar Clinical Trial: 98% of Patients Were White!!!
https://www.bcan.org/wp-content/uploads/2012/10/Steinberg-presentation-final-10-25-12.pdf
Go to slide ten^
Which makes the hour that the adcom committee spent scrutinizing the racial composition of the MCNA clinical trial to be even more irrelevant.
MCNA trial had the same composition as Valstar, which further supports MCNAs superiority
Comment by
ragingbull1327 on Nov 19, 2015 11:25pm
If there are people out there that honestly believe that this won't be approved, for whatever reason, then they should probably reassess what information it is that they find "important" when they are buying and selling stocks.
Comment by
txbioinv on Nov 20, 2015 11:03am
steve, Nice digging, going into my file saving for our FDA PANEL TORPEDO LETTER
Comment by
DamnYankees on Nov 20, 2015 11:56am
I don't think that the FDA is prepared to tell Bladder Cancer patients, survivors, their children, their spouses, some very influential Urlogists who attended Adcomm, and the Urology community as a whole that they are pulling the ripcord on the most promising and approveable treatment it two decades over what did someone call it, a "Goat F$%#*ng".
Comment by
ragingbull1327 on Nov 20, 2015 12:02pm
I think so too, except there is one problem with our theory. The FDA has taken an eternity to get us to this point, so people dying on their watch doesn't seem to bother them..... that might be the scariest part of all.
Comment by
txbioinv on Nov 20, 2015 12:06pm
Yes....lol....that was me, its to point now, I have to laugh, to avoid the anger. im taking a break, I will try my best to copy emails here. this stockhouse posting capabilitys is limited, kind of like mine, lol. GL....stay strong longs. ps- anyone who wishes to inbox me their email address, I will forward emails to them.
Comment by
DamnYankees on Nov 20, 2015 12:31pm
I think it would be best to ask an experienced independant consultant before determining the course of action for any communication with the FDA. That was a devastating setback, and until we see how things play out, near term, who else's judgement in this crisis can really be trusted.